SEC Tracker
Get the app

Tvardi Therapeutics TVRD

Tvardi Therapeutics (TVRD) announced the resignation of its Chief Executive Officer, effective immediately. This unexpected leadership change could signal strategic shifts or operational challenges that investors should monitor closely, as it may impact the company's ability to execute on its clinical development pipeline and commercialization plans.

Form
8-K
Filed
Importance
Major

Open in the appGet the appView on EDGAR

Get an email when Tvardi Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Silence Therapeutics SLN public float $206M, Jun 30, 2025
  2. Cardiff Oncology CRDF public float $205M, Jun 30, 2025
  3. Rezolute RZLT public float $204M, Dec 31, 2025
  4. Natures Sunshine Products NATR public float $211M, Jun 30, 2025
  5. Rocket Pharmaceuticals RCKT public float $213M, Jun 30, 2025